Bristol Myers Squibb (CELG-RI) Net Shares Issued and Repurchased (2011 - 2012)
Bristol Myers Squibb's (CELG-RI) quarterly Net Shares Issued and Repurchased came in at -$11.7 million in Q4 2012, down 8.35% year-over-year from -$12.8 million in Q1 2012, and down 8.35% quarter-over-quarter from -$10.8 million in Q4 2011.
Powered by 
Analysis
Bristol Myers Squibb (CELG-RI) Net Shares Issued and Repurchased (2011 - 2012) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has reported Net Shares Issued and Repurchased for 2 consecutive years, with -$11.7 million the latest figure, recorded in Q4 2012.
- On a quarterly basis, Net Shares Issued and Repurchased fell 8.35% year-over-year to -$11.7 million in Q4 2012; TTM through Dec 2012 was -$11.7 million, a 8.35% decrease from a year earlier, with the FY2012 full-year figure at -$11.7 million, down 8.35% from the prior year.
- Net Shares Issued and Repurchased was -$11.7 million for Q4 2012 at Bristol Myers Squibb, down from -$10.8 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at -$10.8 million in Q4 2011 and troughed at -$11.7 million in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Bristol Myers Squibb | 285.98 Mn | -10.78 Bn | 9.25 Bn | - |